Catalyst Wire Dossier Catalyst Wire Dossier

NOVA22007 0.1% cyclosporine ophthalmic solution

cyclosporine · Santen SAS
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NOVA22007 0.1% cyclosporine ophthalmic solution, covering 2016-06-06 to 2016-06-06. Get the full timeline:

Most recent: Clinical Trial Update: NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye [Phase 2]

See pricing